CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Relapsing or Refractory Multiple Sclerosis (MS) · Myasthenia Gravis (MG) · Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) · Autoimmune Encephalitis (AE)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Principal Investigator (Daishi Tian, Prof.)Contact: Principal Investigator (Chuan Qin, Prof.)
Study leads
Daishi Tian, Prof.
Principal Investigator
Tongji Hospital
Chuan Qin, Prof.
Principal Investigator
Tongji Hospital